Fate Therapeutics
ISIN US31189P1021
|WKN A1W50M
Overview
Description
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 412.43 m |
| EPS, EUR | -1.51 |
| P/B ratio | 1.02 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 58.77 m |
| Net income, EUR | -148.86 m |
| Profit margin | -253.30% |
What ETF is Fate Therapeutics in?
There are 6 ETFs which contain Fate Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Fate Therapeutics is the WisdomTree BioRevolution UCITS ETF USD Acc.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| iShares Ageing Population UCITS ETF | 0.10% | Equity World Health Care Social/Environmental Ageing Population | 337 | 0.40% | 436 | +8.42% | A2ANH1 | IE00BYZK4669 |
| L&G Russell 2000 US Small Cap Quality UCITS ETF | 0.05% | Equity United States Small Cap | 1,046 | 0.30% | 81 | +20.36% | A0Q8H2 | IE00B3CNHJ55 |
| WisdomTree BioRevolution UCITS ETF USD Acc | 2.83% | Equity World Health Care Social/Environmental Biotech | 88 | 0.45% | 2 | -5.23% | A3CY21 | IE000O8KMPM1 |
| iShares Healthcare Innovation UCITS ETF | 0.12% | Equity World Health Care Social/Environmental Innovation | 195 | 0.40% | 962 | +0.60% | A2ANH2 | IE00BYZK4776 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.04% | Equity United States Small Cap | 1,486 | 0.30% | 927 | +20.49% | A1XEJT | IE00BJZ2DD79 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.03% | Equity United States Small Cap | 1,795 | 0.30% | 2,510 | +20.43% | A1XFN1 | IE00BJ38QD84 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.